Biotech

chasing running uphill behind leadership climbing

Biotech

Novo’s triple G prospect passes midphase diabetes test in China

While the data suggest the asset is competitive, Eli Lilly’s headstart in the space means it remains the company to beat.

Nick Paul Taylor Mar 25, 2026 4:30am

obesity pill

BrightGene’s oral drug sees up to 8% weight loss in early data

Mar 25, 2026 4:04am

Avoiding 11th hour surprises in clinical trials

Brought to you by Almac Clinical Services

Large group of people seen from above gathered together in the shape of medicine cross symbol

Icon, Advarra team up to optimize trials, expand access

Mar 24, 2026 4:52pm

How physiology powers biotech innovation

How physiology powers biotech innovation

Brought to you by American Physiological Society

Close up of amber eye

Ocugen eye disease gene therapy nabs underwhelming ph. 2 win

Mar 24, 2026 10:40am